Council briefing series to examine role of public policy in promoting medical innovation

Briefing is the second in a three-part series on "Achieving Recovery Through Discovery"

The Council for American Medical Innovation will host a breakfast briefing on Capitol Hill titled "Translational Research - From Bench to Bedside." Health policy experts will explore important changes needed to improve the process of development and approval for safe and effective drugs, biologics, medical devices and diagnostics. The Council believes a robust infrastructure for translational research that transforms clinical research into practical treatments quickly and efficiently is critical to ensuring new, life-saving medical treatments reach the market.

This is the second in a three-part briefing series examining the role of public policy in promoting medical innovation to help our nation recover from health and economic crises.

WHO: Remarks by:

  • Amy Comstock Rick, CEO of the Parkinson's Action Network
  • The Honorable Patrick Kennedy, U.S. Representative (D-RI) (invited)
  • Debra Lappin, President of the Council for American Medical Innovation
  • Alan Leshner, Ph.D., President of the American Association for the Advancement of Science (AAAS)
  • Lesa Mitchell, Vice President of the Ewing Marion Kauffman Foundation

WHERE: Rayburn House Office Building, Room B338

WHEN: Thursday, September 17, 2009

8:30 - 10:00 a.m.

http://www.americanmedicalinnovation.org/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration